These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22370987)

  • 1. [Small biopsies and cytologic specimens management in microscopic diagnosis and subtyping of non-small cell lung cancer, as recommended by IASLC/ATS/ERS].
    Langfort R; Szołkowska M; Szczepulska-Wójcik E; Maksymiuk B
    Pneumonol Alergol Pol; 2012; 80(2):172-7. PubMed ID: 22370987
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytologic subtyping of lung adenocarcinoma by using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) adenocarcinoma classification.
    Rodriguez EF; Monaco SE; Dacic S
    Cancer Cytopathol; 2013 Nov; 121(11):629-37. PubMed ID: 23943235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in classiffication of primary lung adenocarcinoma according to reccomendations of International Association for the Study of Lung Cancer/ /American Thoracic Society/European Respiratory Society].
    Szołkowska M; Langfort R; Szczepulska-Wójcik E; Maksymiuk B
    Pneumonol Alergol Pol; 2012; 80(2):163-71. PubMed ID: 22370986
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
    Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
    Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact.
    Sterlacci W; Savic S; Schmid T; Oberaigner W; Auberger J; Fiegl M; Tzankov A
    Am J Clin Pathol; 2012 Jun; 137(6):946-56. PubMed ID: 22586054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recommendation concerning the microscopic classification of lung adenocarcinoma presented by International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society].
    Langfort R; Szołkowska M
    Pneumonol Alergol Pol; 2012; 80(2):99-100. PubMed ID: 22370977
    [No Abstract]   [Full Text] [Related]  

  • 8. Staging of non-small cell lung cancer (NSCLC): a review.
    Tsim S; O'Dowd CA; Milroy R; Davidson S
    Respir Med; 2010 Dec; 104(12):1767-74. PubMed ID: 20833010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The international multidisciplinary classification of lung adenocarcinoma from IASLC/ATS/ERS and problems in clinical practice].
    Yan L; Yi X
    Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):333-8. PubMed ID: 23866662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comments on International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society (IASLC/ATS/ERS) International Multidisciplinary Classification of Lung Adenocarcinoma (2011)].
    Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):793-6. PubMed ID: 22336202
    [No Abstract]   [Full Text] [Related]  

  • 11. [Are the ATS (American Thoracic Society) and the ERS (European Respiratory Society) correct in not recommending routine tumor marker assays foeening, staging, or evaluation of non-small cell lung cancer?].
    Watine J; Charet JC
    Rev Mal Respir; 1999 Apr; 16(2):139-49. PubMed ID: 10339757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The new TNM classification in lung cancer].
    Wrona A; Jassem J
    Pneumonol Alergol Pol; 2010; 78(6):407-17. PubMed ID: 21077033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer staging: proposed revisions to the TNM system.
    Schneider BJ
    Cancer Imaging; 2008 Sep; 8(1):181-5. PubMed ID: 18824424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
    Travis WD; Brambilla E; Riely GJ
    J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
    Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchial biopsies--in praise of an H&E section.
    Pandit D; Griffiths D; Edwards J
    Histopathology; 2006 Jul; 49(1):96-7. PubMed ID: 16842256
    [No Abstract]   [Full Text] [Related]  

  • 17. Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification.
    Travis WD; Brambilla E; Van Schil P; Scagliotti GV; Huber RM; Sculier JP; Vansteenkiste J; Nicholson AG
    Eur Respir J; 2011 Aug; 38(2):239-43. PubMed ID: 21804158
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing.
    Travis WD; Rekhtman N
    Semin Respir Crit Care Med; 2011 Feb; 32(1):22-31. PubMed ID: 21500121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genes and pathology of non-small cell lung carcinoma.
    Sakashita S; Sakashita M; Sound Tsao M
    Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small-cell lung carcinoma subtyping on cytology without the use of immunohistochemistry - can we meet the challenge?
    Manucha V; Wang C; Huang Y
    Acta Cytol; 2012; 56(4):413-8. PubMed ID: 22846184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.